Masuyama et al. [29] tested the therapeutic potential of stimulating sGC with BAY 41-2272 administered for 14 days at a low dose (which had no effect on blood pressure) in a rat model of the angiotensin II-induced hypertension and cardiac remodeling. This evidence concerns the gene AGT and hypertensive disorder.